SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Optimark Data Systems Inc. @ Johns Hopkins Hospital

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John E. Jacobs who wrote ()12/2/1998 12:50:00 PM
From: John E. Jacobs  Read Replies (1) of 436
 
Fresh News Release

TMR to extend management agreement until merger is completed

OptiMark Data Systems, Inc ODS
Shares issued 26,407,673 Nov 30 close $0.12
Wed 2 Dec 98 News Release
Mr. Chuck Brocs reports
TMR Corp. has agreed to extend its original management agreement with
Optimark until the merger is completed.
Following are details from ASEI's press release reiterating details of
ASEI's merger terms with NATD, transactions with OPMK shareholders and
notice of other pending acquisitions.
The reserve of AESI shares to complete the merger with National
Diagnostics: Under the merger agreement with NATD shareholders will be
given $3.50 credit for each share of NATD in exchange for AESI stock. The
valuation of AESI shares will be set at $10.00 per share. This share price
is consistent with that of the last five mergers AESI completed.
NATD operates multiple diagnostics centres and mobile equipment. AESI plans
to have NATD develop and staff turnkey diagnostic centres and services for
all AESI community health enterprises.
The reserve of AESI shares to complete the acquisition of at least 80 per
cent of the outstanding shares of Optimark Data Systems: Under the merger
agreement Optimark shareholders will be given $1.00 credit for each share
of Optimark in exchange for AESI stock. AESI stock is to be valued in
accordance with details as previously announced.
Optimark provides sophisticated clinical pathway software systems to
approximately 40 major teaching institutions and other healthcare providers
throughout the United States.
AESI plans to have Optimark develop turnkey clinical pathway systems and
services for all AESI community health enterprises.
AESI continues to move ahead with its merger and acquisition strategy.
The companies targeted are intended to bring to AESI products, services,
facilities and healthcare expertise that complement its delivery systems.
AESI plans to have these companies (if they close) further assist AESI
carry out its mission to design, develop, implement, own, manage and
operate community health enterprises.
WARNING: The company relies on litigation protection for "forward-looking"
statements.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext